Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2016 - 2026)

Cumberland Pharmaceuticals' Shares Outstanding history spans 16 years, with the latest figure at $15.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 7.2% to $15.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.0 million, a 7.2% increase, with the full-year FY2025 number at $15.0 million, up 7.2% from a year prior.
  • Shares Outstanding hit $15.0 million in Q4 2025 for Cumberland Pharmaceuticals, roughly flat from $15.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CPIX hit a ceiling of $15.1 million in Q1 2021 and a floor of $14.0 million in Q4 2024.
  • Historically, Shares Outstanding has averaged $14.6 million across 5 years, with a median of $14.6 million in 2022.
  • Biggest five-year swings in Shares Outstanding: fell 2.73% in 2023 and later grew 7.2% in 2025.
  • Tracing CPIX's Shares Outstanding over 5 years: stood at $14.7 million in 2021, then decreased by 2.55% to $14.4 million in 2022, then decreased by 1.7% to $14.1 million in 2023, then decreased by 1.2% to $14.0 million in 2024, then increased by 7.2% to $15.0 million in 2025.
  • Business Quant data shows Shares Outstanding for CPIX at $15.0 million in Q4 2025, $15.0 million in Q3 2025, and $15.0 million in Q2 2025.